Development and Validation of a KAP Questionnaire for Secondary Hypertension: Evaluating a Commun… (NCT07497841) | Clinical Trial Compass
CompletedNot Applicable
Development and Validation of a KAP Questionnaire for Secondary Hypertension: Evaluating a Community Short-Video Intervention in Rural Beijing
China1,062 participantsStarted 2025-12-01
Plain-language summary
This is a two-phase, non-randomized clinical trial conducted in eight communities in Miyun District, Beijing. The study first develops and validates a reliable 18-item questionnaire (Knowledge, Attitudes, and Practices \[KAP\] scale) to assess community residents' understanding, attitudes, and behaviors related to secondary hypertension. Then, we evaluate whether a 1-week community-centered short-video health education intervention (five 1-minute videos delivered via community WeChat groups by local physicians) can improve residents' secondary hypertension-related knowledge, attitudes, and practices. We will compare scores before and after the intervention, and analyze which groups (such as rural residents, people with lower education, older adults) benefit more. This study aims to provide a simple assessment tool and a scalable health education model for secondary hypertension in community settings, especially for rural and low-educated populations.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Permanent residents aged ≥18 years with basic comprehension abilities, capable of completing the online questionnaire independently or with assistance
* Voluntary participation and signed informed consent
For Phase 2 (Intervention Phase) only:
* Individuals with confirmed hypertension or family members cohabiting with hypertensive patients
* Member of a community WeChat group with the ability to receive and view short videos, and to complete online questionnaires independently or with assistance
Exclusion Criteria:
* \- Cognitive impairment that would interfere with understanding the questionnaire or video content
* Prior participation in standardized secondary hypertension public education programs
* Inability to use WeChat or access short videos (for Phase 2)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in total score of the Secondary Hypertension Knowledge, Attitudes, and Practices (KAP) scale
Timeframe: Baseline (1 day before intervention) and within 24 hours after the 1-week intervention